Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 20, 2019
Pharmacy Choice - News - Drug Delivery Systems - March 20, 2019

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/30/17 - NINDS Awards $150,000 Grant to NuvOx Pharma for Development of Field-Ready Syringe for Oxygen Delivery Drug
NuvOx Pharma, a clinical stage biotechnology company, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke. Evan Unger, MD, President and CEO of NuvOx Pharma, said, "Scientists at NuvOx discovered that application of ultrasound energy to pre-
12/30/17 - pSivida U.S. Assigned Patent for Sustained Release Drug Delivery Devices
pSivida U.S., Watertown, Massachusetts, has been assigned a patent developed by two co-inventors for "sustained release drug delivery devices, methods of use, and methods of manufacturing thereof." The co-inventors are Hong Guo, Wayland, Massachusetts, and Paul Ashton, Newton, Massachusetts. Written by Ranjan Behera; edited by Sudarshan Harpal.
12/30/17 - Zydus Pharmaceuticals gets USFDA nod for OCD treatment drug [Arab News (Saudi Arabia)]
Zydus Pharmaceuticals Inc has received final approval from the US health regulator to market Clomipramine Hydrochloride capsules, used to treat obsessive compulsive disorder. Zydus Pharmaceuticals Inc is a wholly-owned subsidiary of Cadila Healthcare Ltd.. Shares of Cadila Healthcare, the listed entity of the group, were up 1.68 per cent at Rs 432.
12/29/17 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed Refractory AML and an IDH1 Mutation
CAMBRIDGE, Mass.- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for ivosidenib, an investigational oral treatment for patients with relapsed or refractory acute myeloid leukemia
12/29/17 - BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
By a News Reporter-Staff News Editor at Drug Week BioVectra Inc., an innovative global contract development and manufacturing organization, announced a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to manufacture Ferric Citrate, the active pharmaceutical ingredient in Auryxia tablets, a medicine approved for the treatment of
12/29/17 - Buprenorphine Transdermal Patch 10 Mcg / Hr.mfg-modi Mundi Pharma Pvt. Ltd.rusan Pharma Or Similer. [TendersInfo (India)]
Tenders are invited for Buprenorphine transdermal patch 10 mcg/ hr.mfg-modi mundi pharma pvt. Type: Open Major organization: CHITTRANJAN LOCOMOTIVE WORKS Address: Kolkata, West Bengal Country: India Tender notice number: 0920179275 A Notice type: Tender Notice Open date: 2018-01-18. Tender documents: T431083978.html, 431083978. pdf.
12/29/17 - CORIUM INTERNATIONAL, INC. - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the section titled "Selected Financial Data" and the audited financial statements and notes thereto and management's discussion and analysis of financial condition and results of operations for the fiscal year ended Septembe
12/29/17 - Disposable medical supplies; Groups - Concealed latex gloves, Venopunktion and blood collection devices, Central venous catheters, Supplies for regional anesthesia and acid-base determination, Medical needles, Intravenous cannules, Needle arterial, S
Disposable medical supplies; Groups- Concealed latex gloves, Venopunktion and blood collection devices, Central venous catheters, Supplies for regional anesthesia and acid-base determination, Medical needles, Intravenous cannules, Needle arterial, Sternal puncture needles, Catheters and accessories more info: Location: CROATIA BidDate: 12/27/2017..
12/29/17 - FDA Grants INSYS Therapeutics 'Fast Track' Designation for Cannabidiol Oral Solution as Investigational Treatment for Prader-Willi Syndrome
PHOENIX- INSYS Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's cannabidiol oral solution for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder characterized by insatiable appetite in children that often leads to obesity and type 2 diabetes.
12/29/17 - Findings in Antidiabetic Agents Reported from Louvain Drug Research Institute (The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via...
Findings in Antidiabetic Agents Reported from Louvain Drug Research Institute. According to news originating from Brussels, Belgium, by NewsRx correspondents, research stated, "Nanoparticulate based drug delivery systems have been extensively studied to efficiently encapsulate and deliver peptides orally. Our news journalists obtained a quote from.
12/29/17 - Global Ocular Drug Delivery Technology Market to Become Worth US$18.124 Bn During 2017-2025
Albany, NY 12/29/2017 This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel drug delivery technologies, increase in prevalence of macular degeneration& diabetic retinopathy, and favorable regulatory scenario for introd
12/29/17 - Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace Cream
HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2017/ PRNewswire/ Global pharmaceutical leader Mylan N.V. today announced the U.S. launch of Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan's Estrace Cream. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application
12/29/17 - Patent Issued for Intraosseous-Needle Stabilizer and Methods (USPTO 9839740)
By a News Reporter-Staff News Editor at Health& Medicine Week A patent by the inventors Beamer, Cynthia L.; Kilcoin, Chris, filed on February 2, 2011, was published online on December 12, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. One example of an intraosseous device and support device is d
12/28/17 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla for the Prevention of Pregnancy
PRINCETON- Agile Therapeutics, Inc.,, a women's healthcare company, today announced that the U.S. Food and Drug Administration issued a complete response letter in response to the New Drug Application resubmission for the Company's investigational non-daily, low dose combination hormonal contraceptive patch, Twirla. The CRL states that the FDA has.
12/28/17 - Becton, Dickinson & Co. Assigned Patent for Low Dose Prefilled Drug Delivery Device
Becton, Dickinson and Co., Franklin Lakes, New Jersey, has been assigned a patent developed by eight co-inventors for a "low dose prefilled drug delivery device and method." The co-inventors are Margaret Taylor, Groton, Massachusetts, James Bates, Sparta, New Jersey, Roman Tunkel, Burlington, Massachusetts, Jay Butterbrodt, North Andover, Massachus
12/28/17 - Cingulate Therapeutics to Present at 10th Annual Biotech Showcase
Cingulate Therapeutics, LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delivery platform technology, today announced that Cingulate's Chairman and Chief Executive Officer, Shane J Schaffer, will present at the 10th Annual Biotech Showcase? on T
12/28/17 - FDA approves drug to treat dangerously low blood pressure
'Shock, the inability to maintain blood flow to vital tissues, can result in organ failure and death,' said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products in the FDA's Center for Drug Evaluation and Research.' There is a need for treatment options for critically ill hypotensive patients who do not ade
12/28/17 - Glenmark Pharmaceuticals gets final approval for generic Minastrin1 24 Fe Tablets [India Infoline News Service]
Glenmark Pharmaceuticals has been granted final approval by the United States Food& Drug Administration for Norethindrone Acetateand Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets, 1 mg/20 mcg, the generic version of Minastrin 1 24 Fe Tablets, of Allergan Pharmaceuticals International.
12/28/17 - Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets [India Infoline News Service]
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food& Drug Administration for Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets, of Allergan Pharmaceuticals International Limited. Its current portfolio consists of 130 products authorized for distribution in the U.S....
12/28/17 - Global Needle-free Injection Systems Market is estimated to reach $24.9 billion by 2023
Global Needle-free Injection Systems Market was valued at $8.20 billion in 2016, and is estimated to reach $24.9 billion by 2023, growing at a CAGR of 17.4% during the forecast period. Needle free injection technology includes a wide range of drug delivery systems which are used to drive drugs through the skin using any of the forces such as Lore
12/28/17 - Home Infusion Therapy Services Market Projected to Gain Significant Value by 2025: Home infusion therapy services is efficiently putting up the patients requirement, growing demand of the infusion devices in the homecare market.
Albany, NY 12/28/2017 Home infusion therapy services offer an innovative healthcare services at the doorsteps. Infusion therapy administer medication through needle or a catheter. Infusion therapy is generally used when the patient's condition is very severe and cannot be cured with the oral medication.
12/28/17 - Horizon Pharma plc Announces FDA Approval to Expand the Indication for PROCYSBI (cysteamine bitartrate) Delayed-Release Capsules to Include Children One Year of Age and Older Living with Nephropathic Cystinosis [Sudan Tribune]
Horizon Pharma plc today announced the U.S. Food and Drug Administration has approved an expansion to the indication for PROCYSBI delayed-release capsules to include children one year of age and older living with nephropathic cystinosis. PROCYSBI was previously FDA- approved for adults and children as young as two years of age. Data included in the
12/28/17 - MERCK - FDA APPROVES SGLT2 INHIBITOR STEGLATRO AND FIXED-DOSE COMBINATION STEGLUJAN FOR ADULTS WITH TYPE 2 DIABETES
KENILWORTH, N.J.& NEW YORK- Merck, known as MSD outside the United States and Canada, and Pfizer Inc., today announced that the U.S. Food and Drug Administration has approved STEGLATROTM tablets, an oral sodium-glucose cotransporter 2 inhibitor, and the fixed-dose combination STEGLUJAN tablets. STEGLATRO is indicated as an adjunct to diet and exerc
12/28/17 - Researchers Submit Patent Application, "Implantable Medical Device Which May Be Controlled from Central Station", for Approval (USPTO 20170348524)
By a News Reporter-Staff News Editor at Politics& Government Week From Washington, D.C., VerticalNews journalists report that a patent application by the inventor MATOS, JEFFREY A., filed on August 3, 2015, was made available online on December 14, 2017. No assignee for this patent application has been made. News editors obtained the following qu
12/27/17 - Active Implantable Medical Devices Market to Surpass US$ 26,776.9 Million Threshold by 2025 globally
In 2016, Medtronic Plc. was the first company to receive the U.S. Food& Drug Administration approval for leadless pacemaker, Micra. Biotronik received approval for its leadless ICD system, which is first of its kind, in the U.S. in July 2017. Moreover, in 2016, Medtronic plc was the first company to receive FDA approval for magnetic resonance imagi
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415